Skip to main content

. 1992 Jan 18;304(6820):158. doi: 10.1136/bmj.304.6820.158

Octreotide and Graves' ophthalmopathy and pretibial myxoedema.

T C Chang ¹, S C Kao ¹, K M Huang ¹

PMCID: PMC1881144 PMID: 1737161

158

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bauer W., Briner U., Doepfner W., Haller R., Huguenin R., Marbach P., Petcher T. J., Pless SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 1982 Sep 13;31(11):1133–1140. doi: 10.1016/0024-3205(82)90087-x. [DOI] [PubMed] [Google Scholar]
Hansson H. A., Petruson B., Skottner A. Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin. Lancet. 1986 Jan 25;1(8474):218–219. doi: 10.1016/s0140-6736(86)90698-7. [DOI] [PubMed] [Google Scholar]
Kriss J. P. Pathogenesis and treatment of pretibial myxedema. Endocrinol Metab Clin North Am. 1987 Jun;16(2):409–415. [PubMed] [Google Scholar]
Tsuzaki S., Moses A. C. Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-I in FRTL5 cells. Endocrinology. 1990 Jun;126(6):3131–3138. doi: 10.1210/endo-126-6-3131. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES